Mithra Pharmaceuticals SA

ENXTBR:MITRA Stock Report

Market Cap: €14.9m

Mithra Pharmaceuticals SA Company Information

Mithra Pharmaceuticals SA's employee growth, exchange listings and data sources


Key Information

  • Name: Mithra Pharmaceuticals SA
  • Ticker: MITRA
  • Exchange: ENXTBR
  • Founded: 1999
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: €14.927m
  • Shares Outstanding: 69.11m
  • Website: https://www.mithra.com

Number of Employees


Location

  • Mithra Pharmaceuticals SA
  • Rue Saint-Georges 5
  • Liège
  • Liège
  • 4000
  • Belgium


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MITRAENXTBR (Euronext Brussels)YesCommon SharesBEEURJun 2015
MITRAbBATS-CHIXE (BATS 'Chi-X Europe')YesCommon SharesGBEURJun 2015
0R91LSE (London Stock Exchange)YesCommon SharesGBEURJun 2015
1TMDB (Deutsche Boerse AG)YesCommon SharesDEEURJun 2015
MITP.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJun 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/07/15 14:21
End of Day Share Price 2024/07/12 00:00
Earnings2023/12/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.